Companies Directory

The company Neurochlore is developing an innovative therapeutic strategy to ameliorate developmental brain pathologies. Located Luminy (Marseille), the company has formed close links with internationally recognized scientific experts in some fields of developmental Neurobiology and neurological disorders. Furthermore, extensive collaborations with drug developers and clinical experts in neuro-pediatrics and psychiatry enable Neurochlore to develop and test novel applications for its therapeutic agent. Indeed, Neurochlore has an international patent in the use of a diuretic in the treatment of Autism Spectrum Disorders (ASD) and another syndrome associated with autism. Clinical Research Neurochlore is currently developing a treatment which will be able to ameliorate ASD in children and adolescents. The company has already conducted a successful monocentric study (Lemonnier et al., Translational Psychiatry, 2012) and a multicentric phase II clinical trial in order to confirm the efficacy and tolerance of this new treatment (Lemonnier et al., article in press). This study will be soon followed by a double-blind randomized phase III study that, if successful, will allow to submit a registration application to the European health authorities. Fundamental Research Fundamental research at Neurochlore is organized around a wide range of animal models of ASD and syndromes with associated autism. Research topics are focused on the study of developmental sequence modifications of GABAergic/glutamatergic currents in pathologies, focusing in the periods in utero and during birth. To determine the features of malformed brain currents/networks, a large range of techniques is used including electrophysiological recordings of in vitro slices, in vivo recordings, morphological analysis… The fundamental research is financed by external sources notably the Bettencourt Schueller Foundation.

Neurocle is a leading and innovative deep learning vision software company. Our vision is to make deep learning vision technology more accessible. To realize this vision, we developed three deep learning softwares Neuro-T, Neuro-R and Neuro-X. Neuro-T is designed for non-experts and can create high-quality models with just a few clicks. Neuro-R is a Real-Time Inference Engine that run models created in Neuro-T. Neuro-X is designed for deep learning experts, so that they can manage data and create model easily with intuitive GUI. By providing quick and easy solutions for users with high-quality software, we have entered various industries including manufacturing, medical market and played a key role in proceeding big projects. For more information or to rent our software , go to https://www.neuro-cle.com/.

With three decades of industry experience, Neurocom is a leading, data-driven solution provider offering comprehensive fraud and risk management solutions to payment and financial service providers, and regulated entities, assisting them in meeting regulatory obligations, preventing fraud and mitigating risk.

NeuroDigital Technologies provides innovative Hardware solutions for Tactile Virtual Reality, creating advanced technology for haptics, motion capture and Smart Triggering. Our mission is to provide innovative systems and solutions based on Virtual Reality conceived specifically for troubleshooting unsolved problems requiring touch sense, full tracking and manual interaction. These solutions are addressed to a number of areas spanning Industry, Healthcare, Education, Defense, Advertising, Culture... and of course Entertainment.

NeuroDigital Technologies provides innovative Hardware solutions for Tactile Virtual Reality, creating advanced technology for haptics, motion capture and Smart Triggering. Our mission is to provide innovative systems and solutions based on Virtual Reality conceived specifically for troubleshooting unsolved problems requiring touch sense, full tracking and manual interaction. These solutions are addressed to a number of areas spanning Industry, Healthcare, Education, Defense, Advertising, Culture... and of course Entertainment.

Neurodyn utilizes a portfolio approach to identify, validate, and develop bioactives for neuroprotection and the early treatment of neurological diseases. Neurodyn identifies bioactive compounds within historically-proven natural treatments with the goal of validating therapeutic candidates and ultimately developing treatments for Parkinsons, Alzheimers, ALS and chronic nerve pain. Neurodyn will out-license or sell validated therapeutic candidates to pharmaceutical and consumer health players, as well as explore faster alternatives to traditional drug development, such as the US FDA Medical Food designation. Neurodyns unique insight into the discovery, validation, and development of new bioactive compounds comes from a strong development capacity based on international partners with demonstrated historical knowledge of natural compounds, in-house medicinal chemistry capability, and proprietary animal models of neurological disease.

Neurocognitive decision-making of person (fMRI, MEG, PET, EEG, NIRS). Semantic technologies for business applications (OSF). Artificial neural networks - automated technology for working with arrays of unstructured data (Numenta NuPIC, Deep learning). Multiagent simulation - Technology of Information Science for parallel computing with complex network structure (FLAME, JADE). Projects EEG+NIRS working memory structure analyzer Framework of Autonomous Functional Agents Smart home control system Semantic text complexity analyzer Functional MRI-based lie detection Eurasian Agent-based Computational Economic model Neural tissue biofabrication for nootropics design Neurogenetic consulting

NeuroEquilibrium is the world's largest chain of dizziness clinics. With our super-specialty clinics established at prominent government and private hospitals, ENT clinics, and neurology specialty centres across 50+ cities in India, we are transforming the lives of millions of individuals suffering from these debilitating conditions. At the heart of our innovative approach lies our deeptech platform, which seamlessly integrates cloud technology, computer vision, clinical decision support systems, a remote diagnostic platform, and our proprietary diagnostic equipment and systems. This holistic integration empowers our partner clinics to deliver accurate diagnoses and personalised treatment plans, revolutionising the way dizziness and balance disorders are managed.